title: Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.
abstract: Elements of the immune system act as intimate regulators of cancer progression, inhibiting early stages of tumor growth, through immunosurveillance while facilitating later stages of tumor progression. Recent findings have revealed that activated CD8 T cells can stimulate mammary epithelial tumor cells to undergo epithelial-mesenchymal transition (EMT) and to acquire the greatly increased tumorigenic capability and chemotherapeutic resistance of breast cancer stem cells (BCSC). These studies provide a window to understanding how BCSC arise and are maintained within tumors, and how to best target these processes for therapeutic benefit.
authors.affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Reiman
authors.forename: Keith L
authors.initials: KL
authors.lastname: Knutson
authors.forename: Derek C
authors.initials: DC
authors.lastname: Radisky
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000628:therapy*; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D018450:Disease Progression; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D007107:Immune System; D008648:Mesoderm / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000378:metabolism*; D051381:Rats
references.citation: Cancer Cell. 2009 Aug 4;16(2):91-102
references.pmid: 19647220
references.citation: Cell. 2004 Mar 19;116(6):769-78
references.pmid: 15035980
references.citation: Cell. 2009 Aug 21;138(4):645-659
references.pmid: 19682730
references.citation: Am J Pathol. 2007 Sep;171(3):861-71
references.pmid: 17675578
references.citation: Dev Cell. 2008 Jun;14(6):818-29
references.pmid: 18539112
references.citation: Semin Cancer Biol. 2007 Aug;17(4):275-87
references.pmid: 17662614
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2813-20
references.pmid: 18539959
references.citation: Nature. 1994 Feb 17;367(6464):645-8
references.pmid: 7509044
references.citation: Mech Dev. 2003 Nov;120(11):1351-83
references.pmid: 14623443
references.citation: Carcinogenesis. 2008 Oct;29(10):1930-7
references.pmid: 18667445
references.citation: Cancer Res. 2009 Apr 1;69(7):2887-95
references.pmid: 19276366
references.citation: J Am Soc Nephrol. 2004 Feb;15(2):390-7
references.pmid: 14747385
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Cancer Cell. 2005 May;7(5):411-23
references.pmid: 15894262
references.citation: J Clin Invest. 2009 Jun;119(6):1438-49
references.pmid: 19487820
references.citation: Eur J Immunol. 2008 Mar;38(3):640-6
references.pmid: 18266270
references.citation: J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43
references.pmid: 19242781
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Mol Biol Cell. 2003 May;14(5):1790-800
references.pmid: 12802055
references.citation: Mol Cancer Res. 2006 Apr;4(4):221-33
references.pmid: 16603636
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
references.pmid: 19666588
references.citation: J Cell Physiol. 2007 Nov;213(2):374-83
references.pmid: 17680632
references.citation: J Immunol. 2006 Aug 1;177(3):1526-33
references.pmid: 16849459
references.citation: Eur J Immunol. 2007 Mar;37(3):675-85
references.pmid: 17304628
references.citation: PLoS One. 2008 Aug 06;3(8):e2888
references.pmid: 18682804
references.citation: Cancer Cell. 2006 Sep;10(3):227-39
references.pmid: 16959614
references.citation: Annu Rev Immunol. 2004;22:329-60
references.pmid: 15032581